Introduction
============

The tumor suppressor protein p53 is induced in response to many stress signals ([@b12]) and activates various stress-response programs including cell-cycle arrest, senescence, and apoptosis. An important unanswered question is how can a single protein orchestrate such a complex response to different inputs? Much attention in this regard has been focused around the hypothesis that different post-translational modifications of p53 lead to activation of different downstream gene programs ([@b4]; [@b3]). However, another potential level of regulation, which has not been explored as much in this system, is the temporal dynamics of p53.

The dynamical behavior of p53 has been extensively characterized in response to one particular form of DNA damage, double-strand breaks (DSBs) caused by γ-radiation or the radiomimetic drug neocarzinostatin (NCS) ([@b25]). DSBs trigger a series of p53 pulses with fixed amplitude and duration, independent of the damage dose, whereas the number of pulses increases with higher damage ([@b17]; [@b7]). It is not clear whether other types of DNA damage lead to similar dynamical behavior. In addition, the p53 response to DSBs was shown to be excitable---a full p53 pulse is triggered by either a sustained or a transient input ([@b2]; [@b18]). The mechanism generating excitability in the p53 response to DSBs has not yet been determined.

Here we show that different stresses trigger different temporal profiles of p53. We found that the p53 dynamical response to UV significantly differs from the response to DSBs, and we provide new mechanistic insights about the role of feedback controlling specific features of p53 dynamics, such as excitability and input-strength dependency.

Results and discussion
======================

We first set out to determine whether a distinct form of DNA damage leads to a series of undamped pulses as was previously shown in response to DSBs ([@b17]; [@b7]; [@b2]). We chose UV light, which is known to cross-link consecutive pyrimidine bases leading to the exposure of single-stranded DNA (ssDNA). Previous studies showed that population-averaged analysis can mask true dynamical responses ([@b17]; [@b30]); we therefore analyzed p53 dynamics in single cells using a p53-Venus fusion ([@b2]). We found that in response to a single short burst of 2 J/m^2^ UV, p53 showed pulses that were similar in amplitude and duration to the pulses observed in response to DSBs caused by NCS ([Figure 1A and B](#f1){ref-type="fig"}). However, the frequency of the pulses in response to UV was lower and did not appear to be as regular as the pulses in response to DSBs.

To determine whether there was a principal frequency of the UV-induced pulses, we performed pitch detection as was previously described ([@b7]). In contrast to the DSB response that results in a principal period of 4--7 h ([@b7]), a broad distribution of pitches was determined for the UV response ([Supplementary Figure S1](#S1){ref-type="supplementary-material"}), indicating that there was no dominant frequency of p53 pulses. The irregularity of the pulse frequency suggests that later pulses in response to UV might be independent of the extrinsic UV damage, and likely represent pulses resulting from intrinsic damage during normal proliferation as was recently shown ([@b18]).

The amplitude, duration, and frequency of individual p53 pulses in response to DSBs are fixed and do not depend on the damage dose ([@b17]; [@b7]; [Figure 1A, C, E, and G](#f1){ref-type="fig"}). To determine whether this is also the case in response to UV, we irradiated cells with a broad range of UV doses, each delivered in a single burst. We found that higher UV doses increased both the amplitude and the duration of the p53 response ([Figure 1B, D, F, and H](#f1){ref-type="fig"}). No principal frequency was identified by pitch detection for any of the UV doses ([Supplementary Figure S1](#S1){ref-type="supplementary-material"}), indicating that there is no periodicity in the p53 response to UV. This dose-dependent, single p53 pulse in response to UV is in stark contrast to the repeated fixed pulses in response to DSBs ([Figure 1](#f1){ref-type="fig"}; [Supplementary Movies 1](#S1){ref-type="supplementary-material"} and [2](#S1){ref-type="supplementary-material"}).

How can a single protein respond to different inputs with such markedly different dynamics? To address this question, we searched for differences in the architecture of the networks responding to DSBs or to UV. In both networks, PI3 kinase-related kinases (ATM or ATR) relay the damage signal to p53, activating two core negative-feedback loops ([Figure 2A and B](#f2){ref-type="fig"}). One feedback loop is between p53 and the E3 ubiquitin ligase Mdm2, in which p53 activates Mdm2 expression and Mdm2 targets p53 for degradation ([@b1]; [@b31]; [@b10]; [@b16]). The other feedback is between p53 and the phosphatase Wip1, in which p53 activates Wip1 expression and Wip1 dephosphorylates p53, thus reducing its stability ([@b6]; [@b19]). However, we noted one main difference: the network responding to DSBs includes a negative feedback between p53 and ATM mediated by Wip1 ([@b27]; [Figure 2A](#f2){ref-type="fig"}, red inhibitory arrow). In contrast, as Wip1 acts through dephosphorylation, and ATR does not require phosphorylation for its activity ([@b5]), we assumed no direct inhibition of ATR by Wip1 ([Figure 2B](#f2){ref-type="fig"}). To determine the contribution of the Wip1-ATM feedback to p53 dynamics, we used our mathematical model of p53 pulses in response to DSBs ([@b2]; [Figure 2C](#f2){ref-type="fig"}) and removed the negative feedback from Wip1 to ATM ([Supplementary information](#S1){ref-type="supplementary-material"}). This perturbation was sufficient for switching p53 dynamics from repeated pulses into a single pulse ([Supplementary Figure S2](#S1){ref-type="supplementary-material"}). In addition, our model predicts that, in contrast to the pulsatile dynamics of ATM in response to DSBs ([@b2]; [Figure 2E](#f2){ref-type="fig"}), active ATR will show a single continuous pulse with a duration that depends on the level of UV ([Supplementary Figure S2](#S1){ref-type="supplementary-material"}). Western blot analysis of ATR activity in response to low and high UV was consistent with this prediction ([Figure 2F](#f2){ref-type="fig"}). To computationally recapitulate the dose-dependent amplitude of p53 pulses observed experimentally in response to UV ([Figure 1F](#f1){ref-type="fig"}), we were required to vary the production rate of active ATR in a dose-dependent manner ([Supplementary information](#S1){ref-type="supplementary-material"}; [Figure 2D](#f2){ref-type="fig"}). Indeed, we found experimentally that the levels of ATR substrate, Chk1-P, depended on the UV dose ([Figure 2F](#f2){ref-type="fig"}). Although these data cannot rule out the possibility that Chk1-P levels might be regulated by an ATR-independent phosphatase, our results are consistent with a dose-dependent ATR activity. In agreement, in our previous work we showed that modulation of the DSB network by Wip1 knockdown resembled the UV response, generating a dose-dependent p53 response to DSBs ([@b2]).

Our model and network diagrams ([Figure 2A and B](#f2){ref-type="fig"}) display a complete separation between the DSBs/ATM and the UV/ATR pathways. However, previous studies have shown cross-talk between the two pathways ([@b14]; [@b32]). We therefore sought to determine the extent of cross-talk in our system and its potential impact on p53 dynamics. We measured the levels of Chk2-P (ATM target) and the levels of Chk1-P (ATR target) in response to γ and UV. Our results show relatively low levels of cross-talk between the pathways ([Figure 2G and H](#f2){ref-type="fig"}; [Supplementary information](#S1){ref-type="supplementary-material"}). We simulated the experimentally measured cross-talk and found minimal effect on p53 dynamics compared with simulations in which cross-talk was absent ([Supplementary Figure S3](#S1){ref-type="supplementary-material"}; [Supplementary information](#S1){ref-type="supplementary-material"}). We concluded that the low level of cross-talk between the DSB and UV pathways does not alter the dynamical behavior of p53.

We next asked whether the p53 response to UV exhibits excitable behavior as was shown in response to DSBs ([@b2]; [@b18]; [Figure 3A and C](#f3){ref-type="fig"}). A hallmark of excitability is that a transient input is sufficient for triggering a full response. We generated a transient input signal by challenging cells with UV and inhibiting ATR 1 h post-damage, using the PI3-kinase-like kinase inhibitor wortmannin ([@b24]; [Supplementary Figure S4](#S1){ref-type="supplementary-material"}). We found that in response to UV, p53 immediately stopped accumulating when the upstream damage signal was inhibited ([Figure 3B and D](#f3){ref-type="fig"}; [Supplementary Figure S5](#S1){ref-type="supplementary-material"}). These results show that the p53 response to UV, as opposed to the response to DSBs, is not excitable. Wortmannin is a broad-range inhibitor and we therefore cannot exclude the possibility that the p53 pulse is halted because of the inhibition of other PI3-kinase-like kinases. However, as ATR is the kinase dominating the response to UV, and we show a complete inhibition of ATR activity in the presence of wortmannin ([Supplementary Figure S4](#S1){ref-type="supplementary-material"}), lack of excitability in response to UV supports the suggestion that the p53 response depends on continuous activation of ATR.

We next sought to identify possible mechanisms that could generate excitability in response to DSBs but not in response to UV. One mechanism for generating excitability is to have a fast positive feedback ([@b11]; [@b29]). The currently known positive feedbacks in the p53 response to DSBs function on a transcriptional timescale ([@b9]), and therefore are not likely to act quickly enough to generate the observed behavior. Another possible mechanism for generating excitable behavior is fast removal of an inhibitor, ([@b29]; [@b13]), such as Mdm2. Indeed, [@b28] showed that Mdm2 is rapidly degraded in response to NCS ([@b28]). In our previous work, we showed computationally that ATM-mediated degradation of Mdm2 contributes to the accumulation of p53 in response to DSBs ([@b2]). It is possible that Mdm2 is not rapidly degraded in the early response to UV, preventing p53 excitability. Indeed, we found that Mdm2 levels slowly decrease in response to UV compared with a rapid, relatively large degradation in response to DSBs ([Figure 3G](#f3){ref-type="fig"}).

The differential regulation of Mdm2 in response to DSBs and UV can be explained by the differential phosphorylation of Mdm2 in response to these stresses. In response to DSBs, Mdm2 is phosphorylated by ATM on Ser-395 ([@b15]; [@b21]; [@b22]). This phosphorylation destabilizes Mdm2 by increasing its autoubiquitination and subsequent proteasomal degradation ([@b28]) ([Figure 3E](#f3){ref-type="fig"}). In contrast, UV radiation leads to phosphorylation on residue Ser-407 ([@b26]), which inhibits Mdm2 activity ([Figure 3F](#f3){ref-type="fig"}). UV therefore reduced p53 access by Mdm2 through a post-translational modification, which is rapidly reversible; in contrast, DSBs cause degradation of Mdm2, which takes longer to reverse as mRNA and protein synthesis operate on a slower timescale than dephosphorylation (hours compared with minutes).

To determine whether the rapid degradation of Mdm2 in response to DSBs contributes to the excitability of p53, we mutated Ser-395 of Mdm2 to alanine and monitored Mdm2 and p53 dynamics. The alanine substitution prevented the degradation of Mdm2 in the initial response to DNA DSBs ([Figure 3H](#f3){ref-type="fig"}). Transient transfection of the mutated Mdm2 plasmid revealed that this form of Mdm2, even in the presence of endogenous Mdm2, reduced the percentage of cells that showed an excitable p53 pulse ([Figure 3I and J](#f3){ref-type="fig"}) in response to DSBs. These results suggest that the rapid degradation of Mdm2, mediated by ATM in response to DSBs, contributes to the excitable behavior of p53. In contrast, lack of rapid Mdm2 degradation in the initial UV response results in non-excitable activation of p53.

In summary, we showed how p53, a single transcription factor responding to multiple stresses in human cells, can transmit distinct signals by eliciting different dynamical patterns; DSBs lead to a series of excitable pulses, whereas UV leads to a graded, non-excitable single pulse. Comparison of the networks responding to these types of damage allowed us to identify and validate, both experimentally and computationally, the molecular mechanisms responsible for specific features of p53 dynamics; activation of the core p53--Mdm2-feedback loop by ATR generates a graded single pulse, the feedback from Wip1 to ATM is required for repeated fixed pulses, and the rapid degradation of Mdm2 contributes to the excitable behavior of p53.

It is intriguing to ask why excitability evolved in response to DSBs but not UV. One potential explanation is that DSBs are more harmful to cells than UV-induced DNA lesions, as they can give rise to gross chromosomal aberrations. It makes sense that the system would be poised to respond to DSBs by triggering a p53 pulse as a precaution ([@b18]). In addition, the frequency of ATR-activating stress (e.g. ssDNA) during normal growth is much greater than the frequency of DSBs. It may be detrimental to excite a full p53 response every time ssDNA is detected, unnecessarily activating cell-cycle arrest or apoptosis.

Our study also raises the question of whether the dynamical response of p53 to other types of stress (such as hypoxia, ribosomal stress, and oncogenic activation) correspond to one of the identified classes of dynamics (excitable pulses or a graded response), or whether new dynamical behaviors can be identified. Moreover, as DSBs and UV are known to activate distinct targets of p53 ([@b33]), it is tempting to speculate that the stimulus-dependent dynamics of p53 contribute to this differential regulation. Such a connection has already been shown in other organisms including bacteria ([@b29]) and yeast ([@b8]), and in other systems in mammalian cells. For example, stimulation of PC-12 cells with epidermal growth factor was found to generate a transient Erk kinase activity, resulting in cellular proliferation. In contrast, stimulation with neuronal growth factor led to sustained Erk activity, resulting in differentiation ([@b20]; [@b23]). Further quantitative investigations of p53 dynamics and cellular outcomes in response to various sources of stress are required to determine whether distinct p53 dynamics are decoded differently by various downstream programs, which will provide new opportunities for controlling individual cell fate decisions.

Materials and methods
=====================

Plasmids and cells
------------------

We maintained human breast cancer epithelial MCF7 cells at 37°C in RPMI supplemented with 10% fetal calf serum, 100 U/ml penicillin, 100 μg/ml streptomycin, and 250 ng/ml fungizone (Gemini Bio-Products). MCF7-p53-Venus ([@b2]) was grown in medium supplemented with 400 μg/ml of G418. For UV-irradiated cells, we used RPMI lacking riboflavin and phenol red (transparent medium). For experiments involving wortmannin, we replaced the medium with fresh medium containing 100 μM wortmannin every hour because of the instability of this compound in solution.

To generate the plasmid pMdm2, we used MultiSite-Gateway recombination (Invitrogen). We amplified an ∼3.6-kb portion of the Mdm2 promoter, the Mdm2 cDNA, and a polyA tail individually by PCR with primers containing *attB* sites, and cloned each into pDONR plasmids by recombination (BP clonase, Invitrogen). We then generated a fusion construct by three-fragment recombination (LR Clonase Plus, Invitrogen) using the pDONR plasmids and a modified pDESTR4R3 vector containing a puromycin selection marker. To generate pMdm2S395A, we first used site-directed mutagenesis (Stratagene) to convert the TCT codon 395 to a GCT codon in the Mdm2 cDNA donor vector. We then used three-fragment recombination with the donor vectors for the Mdm2 promoter and the polyA tail. We transfected plasmid pMdm2S395A into MCF7 cells expressing p53-Venus using FuGene6 transfection reagent (Roche). Westerns were performed 48 h after transfection. In microscopy experiments, we identified cells that received the plasmid by co-transfecting an additional plasmid that constitutively expresses mCherry from the CMV promoter (pmCherry). pmCherry was constructed by inserting the sequence encoding the red fluorescent protein mCherry into the C1 expression vector (Clontech). Cells were imaged 3 days after transfection as described below in time-lapse microscopy. Only cells expressing mCherry were analyzed.

DNA damage was induced in cells using a cobalt-60 γ source, NCS (Sigma), or a UV-C 254 nm light source (Ushio). γ-Irradiation was given in a single burst lasting \<4 min. NCS has been shown to act solely within 5 min following addition of the drug to the cell culture medium ([@b25]). The timescale of NCS treatment was therefore comparable to that of γ-irradiation. UV was delivered to cells using a UV lamp with a rate of 1.5 J/m^2^/s. All UV treatments, therefore, were performed in a single burst lasting \<7 s.

Immunoblots
-----------

We harvested cells and obtained protein samples by lysis, quantifying the total protein concentration by Bradford assay. We separated equal amounts of total protein by electrophoresis on 4--12% Bis-Tris gradient gels (Invitrogen). We detected p53 using DO-1 monoclonal antibody (mAb; Santa Cruz Biotechnology), Mdm2 using SMP14 mAb (Santa Cruz Biotechnology), phospho-Chk1(S317) using a rabbit polyclonal antibody (Cell Signaling Technology), phospho-ATM(S1981) using a mAb (Rockland), β-tubulin using E7 mAb (Developmental Studies Hybridoma Bank), and actin using AC-74 mAb (Sigma). We quantified blot images using ImageJ (NIH).

Time-lapse microscopy
---------------------

Two days before microscopy, we grew cells in poly-[D]{.smallcaps}-lysine-coated glass-bottom plates (MatTek Corporation) in transparent medium supplemented with 5% fetal calf serum, 100 U/ml penicillin, 100 μg/ml streptomycin, and 250 ng/ml fungizone (Gemini Bio-Products). We imaged cells with a Nikon Eclipse Ti-inverted fluorescence microscope (Nikon) on which the stage was surrounded by an enclosure to maintain constant temperature, CO~2~ concentration, and humidity. Images of cells in all experiments were taken every 20 min. The Venus filter set was 500/20 nm excitation, 515 nm dichroic beam splitter, and 520 nm emission (Chroma). The mCherry filter set was 545/20--25 nm excitation, 570 nm dichroic beam splitter, and 600/50--25 nm emission (Chroma). We analyzed images using MetaMorph software (Molecular Devices) and custom-written Matlab software (Mathworks). We used a semi-automated method in which cells are segmented manually using brightfield images, followed by automated analysis of the fluorescence images using custom Matlab software ([@b2]; [@b18]). Background-subtracted fluorescence levels were used when reporting traces of p53-Venus intensity. Fluorescence levels without background subtraction were used when reporting histograms of the ratios of fluorescence levels.
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![Stimulus-dependent dynamics of p53 in response to NCS (DSBs) and to UV. (**A**--**D**) Representative traces of MCF7 cells expressing p53-Venus exposed to 100 (**A**) or 400 ng/ml (**C**) of NCS or to 2 (**B**) or 8 J/m^2^ (**D**) UV at the indicated time following treatment. (**E**, **F**) p53-Venus levels averaged over the traces of cells in response to various levels of NCS and UV. Note that for NCS, the averaged response is shown only for the first p53 pulse, as synchrony between cells is lost in subsequent pulses. Each experiment includes between 60 and 110 cells. The mean trace was normalized to the mean p53-Venus of the first time point. (**G**, **H**) Quantification of the relative amplitude and full-width half-maximum duration of all p53 pulses in response to NCS (**G**) or the first pulse in response to UV (**H**). Error bars represent s.e.m.](msb201120-f1){#f1}

![A single feedback switches repeated, fixed p53 pulses into a single dose-dependent pulse. (**A**, **B**) Diagrams showing key species of the p53 signaling networks in response to DSBs (**A**) and UV (**B**). Dashed lines indicate transcription; solid lines indicate protein--protein interactions. (**C**, **D**) Simulated p53 levels in response to DSBs (**C**) and UV (**D**). See [Supplementary information](#S1){ref-type="supplementary-material"} for a description of the model. (**E**--**H**) Western blot analysis of ATM activity (measured by Chk2-P) and ATR activity (measured by Chk1-P) in cells irradiated with γ or UV. Quantification of Chk1-P and Chk2-P levels were normalized to tubulin levels. Error bars represent s.e.m. of triplicate experiments.](msb201120-f2){#f2}

![Differential p53 excitability between DSBs and UV results from differential regulation of Mdm2. (**A**--**D**) Cells expressing p53-Venus were treated with NCS (**A**) or UV (**B**). One hour after damage, medium containing DMSO (control) or wortmannin (+Wm) ([@b24]) was added (dashed line). Representative single-cell traces of average p53-Venus intensity are shown for each condition. (**C**) Histogram of the ratio of peak p53-Venus intensity, α, to p53-Venus intensity at time of DMSO or Wm addition, β, for the experiment shown in (**A**) (\>100 cells/condition). (**D**) Histogram of the ratio of p53-Venus intensity at 6 h after UV, α, to p53-Venus intensity at time of DMSO or Wm addition, β, for the experiment shown in (**B**) (\>80 cells/condition). (**E**, **F**) Diagrams showing the differences in the negative regulation of Mdm2 by ATM (**E**) and ATR (**F**). (**G**) Western blot analysis and quantification of Mdm2 levels in cells irradiated with γ or UV. Error bars represent s.e.m. of triplicate experiments. (**H**) Western blot analysis and quantification of WT and mutant Mdm2 levels following γ treatment. Note that bands include both endogenous and exogenous Mdm2 or Mdm2S395A. Error bars represent s.e.m. of triplicate experiments. (**I**) Representative traces of average p53-Venus intensity for cells transfected with control or mutant Mdm2 plasmid in response to NCS. DMSO (control) or wortmannin (+Wm) was added 30 min after NCS treatment (dashed line). (**J**) The percentage of cells that show a p53-Venus pulse for the experiment in (**I**) (60--100 cells/condition). Error bars represent s.e.m.](msb201120-f3){#f3}
